Tomoyoshi Takenaka

5PUBLICATIONS
14CO-AUTHORS
Cell physiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 01, 2025
Identifying Key Variances in Clinical Pathways Associated With Prolonged Hospital Stays Using Machine Learning and ePath Real-World Data: Model Development and Validation Study.

Saori Tou, Koutarou Matsumoto, Asato Hashinokuchi

|Aug 12, 2025
Clinical and biological impact of SNAT7 in lung adenocarcinoma: implications for prognosis and treatment.

Asato Hashinokuchi, Naoki Haratake, Yuya Ono

|Apr 27, 2025
CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection.

Kyoto Matsudo, Kazuki Takada, Asato Hashinokuchi

|May 05, 2023
Is radical local therapy effective in postoperative recurrent EGFR-mutated non-small cell lung cancer?

Tomoyoshi Takenaka, Tokujiro Yano, Koji Yamazaki

|Apr 27, 2023
Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma.

Fumihiko Kinoshita, Mototsugu Shimokawa, Tomoyoshi Takenaka

Pageof 1

Frequent Collaborators

2 joint publications

Fumihiko Kinoshita

1 joint publications

Mototsugu Shimokawa

1 joint publications

Koji Yamazaki

1 joint publications

Shinkichi Takamori